KR101175687B1 - 성장인자 복합체 및 세포 이동 및 성장의 조절 - Google Patents

성장인자 복합체 및 세포 이동 및 성장의 조절 Download PDF

Info

Publication number
KR101175687B1
KR101175687B1 KR1020057014530A KR20057014530A KR101175687B1 KR 101175687 B1 KR101175687 B1 KR 101175687B1 KR 1020057014530 A KR1020057014530 A KR 1020057014530A KR 20057014530 A KR20057014530 A KR 20057014530A KR 101175687 B1 KR101175687 B1 KR 101175687B1
Authority
KR
South Korea
Prior art keywords
gly
delete delete
ser
arg
pro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1020057014530A
Other languages
English (en)
Korean (ko)
Other versions
KR20050103288A (ko
Inventor
지 업톤
크리스토퍼 루크 타운
Original Assignee
퀸스랜드 유니버시티 오브 테크놀로지
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 퀸스랜드 유니버시티 오브 테크놀로지 filed Critical 퀸스랜드 유니버시티 오브 테크놀로지
Publication of KR20050103288A publication Critical patent/KR20050103288A/ko
Application granted granted Critical
Publication of KR101175687B1 publication Critical patent/KR101175687B1/ko
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/61—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/65—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/50—Fusion polypeptide containing protease site

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Endocrinology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Dermatology (AREA)
  • Diabetes (AREA)
  • Oncology (AREA)
  • Reproductive Health (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biomedical Technology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Materials For Medical Uses (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
KR1020057014530A 2003-02-05 2004-02-05 성장인자 복합체 및 세포 이동 및 성장의 조절 Expired - Fee Related KR101175687B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2003900481A AU2003900481A0 (en) 2003-02-05 2003-02-05 Synthetic modulators of cell migration and growth
AU2003900481 2003-02-05

Related Child Applications (1)

Application Number Title Priority Date Filing Date
KR1020127007401A Division KR101179678B1 (ko) 2003-02-05 2004-02-05 성장인자 복합체 및 세포 이동 및 성장의 조절

Publications (2)

Publication Number Publication Date
KR20050103288A KR20050103288A (ko) 2005-10-28
KR101175687B1 true KR101175687B1 (ko) 2012-08-22

Family

ID=30005181

Family Applications (2)

Application Number Title Priority Date Filing Date
KR1020057014530A Expired - Fee Related KR101175687B1 (ko) 2003-02-05 2004-02-05 성장인자 복합체 및 세포 이동 및 성장의 조절
KR1020127007401A Expired - Fee Related KR101179678B1 (ko) 2003-02-05 2004-02-05 성장인자 복합체 및 세포 이동 및 성장의 조절

Family Applications After (1)

Application Number Title Priority Date Filing Date
KR1020127007401A Expired - Fee Related KR101179678B1 (ko) 2003-02-05 2004-02-05 성장인자 복합체 및 세포 이동 및 성장의 조절

Country Status (13)

Country Link
US (1) US7659367B2 (enExample)
EP (3) EP1594895B1 (enExample)
JP (2) JP4717799B2 (enExample)
KR (2) KR101175687B1 (enExample)
CN (1) CN1774448B (enExample)
AT (1) ATE521636T1 (enExample)
AU (1) AU2003900481A0 (enExample)
CA (1) CA2515335C (enExample)
DK (1) DK1594895T3 (enExample)
ES (1) ES2372388T3 (enExample)
NZ (1) NZ541738A (enExample)
WO (1) WO2004069871A1 (enExample)
ZA (1) ZA200506991B (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8871709B2 (en) * 2003-02-05 2014-10-28 Queensland University of Technolgy Synthetic chimeric proteins comprising epidermal growth factor and vitronectin
AU2003903896A0 (en) * 2003-07-28 2003-08-07 Queensland University Of Technology Skin regeneration system
US20070003541A1 (en) * 2005-07-01 2007-01-04 Rodolfo Faudoa Methods and compositions for therapeutics
US20070004037A1 (en) * 2005-07-01 2007-01-04 Rodolfo Faudoa Methods and compositions for culturing keratinocytes
US20070128685A1 (en) * 2005-07-01 2007-06-07 Rodolfo Faudoa Methods and compositions for cell culture
US20070004036A1 (en) * 2005-07-01 2007-01-04 Rodolfo Faudoa Methods and compositions for keratinocyte culture
US20090087907A1 (en) * 2005-07-29 2009-04-02 Alice Pebay Compositions and Methods for Growth of Pluripotent Cells
WO2008109123A2 (en) * 2007-03-06 2008-09-12 Tyco Healthcare Group Lp Wound closure material
US20100076489A1 (en) * 2007-03-06 2010-03-25 Joshua Stopek Wound closure material
NZ595731A (en) 2009-03-19 2013-09-27 Univ Queensland Targets for growth factor signalling and methods of therapy
NZ600454A (en) * 2009-11-30 2014-10-31 Univ Queensland Fibronectin: growth factor chimeras
US9133266B2 (en) * 2011-05-06 2015-09-15 Wisconsin Alumni Research Foundation Vitronectin-derived cell culture substrate and uses thereof
CA2856255C (en) 2011-11-23 2021-06-22 Bioven 3 Limited Recombinant proteins and their therapeutic uses
KR20150134417A (ko) * 2013-03-29 2015-12-01 메리맥 파마슈티컬즈, 인크. 연골-결합 융합 단백질
KR101558498B1 (ko) 2013-04-26 2015-10-12 건국대학교 산학협력단 노년황반변성의 진단, 치료 및 예방용 조성물 및 노년황반변성에 대한 진단 방법
WO2015037622A1 (ja) * 2013-09-10 2015-03-19 富士フイルム株式会社 多能性幹細胞の培養方法、培養用キット及び多能性幹細胞培養用培地
WO2016105332A1 (en) * 2014-12-22 2016-06-30 Avon Products, Inc. Peptides and their use in the treatment of skin
US20170281507A1 (en) * 2014-12-23 2017-10-05 Avon Products, Inc. Peptides and Their Use in the Treatment of Skin
WO2016105375A1 (en) * 2014-12-23 2016-06-30 Avon Products, Inc. Peptides and their use in the treatment of skin
ES2873379T3 (es) * 2015-03-11 2021-11-03 Allgenesis Biotherapeutics Inc Proteína de fusión que comprende un dominio de unión a ligando de VEGF y PDGF
WO2019010533A1 (en) * 2017-07-12 2019-01-17 Factor Therapeutics Limited TREATMENT OF OCULAR DISORDERS
CN119278210A (zh) * 2022-06-02 2025-01-07 奥方特蛋白质科技有限公司 基因工程酵母细胞、其产生的重组蛋白及其应用

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002024219A1 (en) 2000-09-22 2002-03-28 Queensland University Of Technology Growth factor complex

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US592904A (en) 1897-11-02 Drill
US4849338A (en) 1982-07-16 1989-07-18 Syntex (U.S.A.) Inc. Simultaneous calibration heterogeneous immunoassay
US4843000A (en) 1979-12-26 1989-06-27 Syntex (U.S.A.) Inc. Simultaneous calibration heterogeneous immunoassay
US4366241A (en) 1980-08-07 1982-12-28 Syva Company Concentrating zone method in heterogeneous immunoassays
GB8607679D0 (en) 1986-03-27 1986-04-30 Winter G P Recombinant dna product
US5091513A (en) 1987-05-21 1992-02-25 Creative Biomolecules, Inc. Biosynthetic antibody binding sites
WO1990000569A1 (en) 1988-07-15 1990-01-25 Central Sydney Area Health Service Acid-labile subunit (als) of insulin-like-growth factor (igf) binding protein complex
US6090790A (en) 1989-12-14 2000-07-18 Eriksson; Elof Gene delivery by microneedle injection
JP2866134B2 (ja) * 1990-02-05 1999-03-08 寳酒造株式会社 機能性ポリペプチド
WO1992001813A1 (en) 1990-07-25 1992-02-06 Syngene, Inc. Circular extension for generating multiple nucleic acid complements
US6054122A (en) 1990-11-27 2000-04-25 The American National Red Cross Supplemented and unsupplemented tissue sealants, methods of their production and use
JP2829405B2 (ja) * 1991-10-14 1998-11-25 寳酒造株式会社 機能性ポリペプチド
US5958764A (en) 1992-04-30 1999-09-28 Baylor College Of Medicine Specific expression vectors and methods of use
WO1994018232A1 (en) 1993-02-12 1994-08-18 Repligen Corporation Methods for generating broadly neutralizing anti-hiv antibodies and antigens capable of eliciting same
US5422252A (en) 1993-06-04 1995-06-06 Becton, Dickinson And Company Simultaneous amplification of multiple targets
US5962427A (en) 1994-02-18 1999-10-05 The Regent Of The University Of Michigan In vivo gene transfer methods for wound healing
AUPM672594A0 (en) 1994-07-08 1994-08-04 Royal Children's Hospital Research Foundation A method for the prophylaxis and/or treatment of proliferative and/or inflammatory skin disorders
US6143495A (en) 1995-11-21 2000-11-07 Yale University Unimolecular segment amplification and sequencing
US5752019A (en) 1995-12-22 1998-05-12 International Business Machines Corporation System and method for confirmationally-flexible molecular identification
US5835382A (en) 1996-04-26 1998-11-10 The Scripps Research Institute Small molecule mimetics of erythropoietin
US6077987A (en) 1997-09-04 2000-06-20 North Shore-Long Island Jewish Research Institute Genetic engineering of cells to enhance healing and tissue regeneration
AU3192299A (en) 1998-03-18 1999-10-11 Wake Forest University Improved implantable biomaterials, compositions and methods for their preparation and uses thereof
US6436897B2 (en) 1998-06-01 2002-08-20 Celtrix Pharmaceuticals, Inc. Pharmaceutical formulations for IGF/IGFBP
JP2001190280A (ja) * 1999-02-19 2001-07-17 Terumo Corp コラーゲン結合性生理活性ポリペプチド
AU3897200A (en) 1999-03-18 2000-10-04 Hope Heart Institute, The Endothelial cell stimulation by a complex of fibronectin and vascular endothelial growth factor
JP2002060400A (ja) * 2000-08-17 2002-02-26 Terumo Corp コラーゲン結合活性および血管新生調節活性を有するハイブリッドポリペプチド

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002024219A1 (en) 2000-09-22 2002-03-28 Queensland University Of Technology Growth factor complex

Also Published As

Publication number Publication date
ES2372388T3 (es) 2012-01-19
KR20120051747A (ko) 2012-05-22
CA2515335C (en) 2013-07-30
US20060194292A1 (en) 2006-08-31
EP2357195A1 (en) 2011-08-17
US7659367B2 (en) 2010-02-09
WO2004069871A1 (en) 2004-08-19
KR20050103288A (ko) 2005-10-28
CN1774448A (zh) 2006-05-17
EP1594895A4 (en) 2007-05-09
ZA200506991B (en) 2006-06-28
JP2007523598A (ja) 2007-08-23
DK1594895T3 (da) 2011-12-12
EP1594895A1 (en) 2005-11-16
HK1091216A1 (en) 2007-01-12
CA2515335A1 (en) 2004-08-19
JP2011120595A (ja) 2011-06-23
AU2003900481A0 (en) 2003-02-20
EP2357195B1 (en) 2016-06-29
CN1774448B (zh) 2012-07-18
KR101179678B1 (ko) 2012-09-04
EP1594895B1 (en) 2011-08-24
EP2357194A1 (en) 2011-08-17
NZ541738A (en) 2006-03-31
ATE521636T1 (de) 2011-09-15
JP4717799B2 (ja) 2011-07-06

Similar Documents

Publication Publication Date Title
KR101175687B1 (ko) 성장인자 복합체 및 세포 이동 및 성장의 조절
US8871709B2 (en) Synthetic chimeric proteins comprising epidermal growth factor and vitronectin
EP2507261B1 (en) Fibronectin: growth factor chimeras
US20100143442A1 (en) Growth factor complexes and modulation of cell migration and growth
AU2004208856B2 (en) Growth factor complexes and modulation of cell migration and growth
HK1160865A (en) Growth factor complexes and modulation of cell migration and growth
HK1160866A (en) Growth factor complexes and modulation of cell migration and growth
HK1091216B (en) Growth factor complexes and modulation of cell migration and growth
HK1160866B (en) Growth factor complexes and modulation of cell migration and growth
HK1176360A (en) Fibronectin: growth factor chimeras
HK1176360B (en) Fibronectin: growth factor chimeras
HK1183908B (en) Vitronectin:keratinocyte growth factor chimeras

Legal Events

Date Code Title Description
E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

R18-X000 Changes to party contact information recorded

St.27 status event code: A-3-3-R10-R18-oth-X000

A201 Request for examination
AMND Amendment
E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

AMND Amendment
E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E601 Decision to refuse application
PE0601 Decision on rejection of patent

St.27 status event code: N-2-6-B10-B15-exm-PE0601

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

A107 Divisional application of patent
AMND Amendment
E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

J201 Request for trial against refusal decision
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0104 Divisional application for international application

St.27 status event code: A-0-1-A10-A18-div-PA0104

St.27 status event code: A-0-1-A10-A16-div-PA0104

PJ0201 Trial against decision of rejection

St.27 status event code: A-3-3-V10-V11-apl-PJ0201

PB0901 Examination by re-examination before a trial

St.27 status event code: A-6-3-E10-E12-rex-PB0901

B701 Decision to grant
PB0701 Decision of registration after re-examination before a trial

St.27 status event code: A-3-4-F10-F13-rex-PB0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

FPAY Annual fee payment

Payment date: 20150716

Year of fee payment: 4

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

PN2301 Change of applicant

St.27 status event code: A-5-5-R10-R11-asn-PN2301

PN2301 Change of applicant

St.27 status event code: A-5-5-R10-R14-asn-PN2301

FPAY Annual fee payment

Payment date: 20160720

Year of fee payment: 5

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 5

FPAY Annual fee payment

Payment date: 20170719

Year of fee payment: 6

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 6

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 7

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 8

PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20200815

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20200815